Edward Visse
11 – 20 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation
(
- Contribution to journal › Article
- 2016
-
Mark
Preoperative systemic levels of VEGFA, IL-7, IL-17A, and TNF-β delineate two distinct groups of children with brain tumors
(
- Contribution to journal › Article
- 2015
-
Mark
A standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays.
(
- Contribution to journal › Article
-
Mark
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.
(
- Contribution to journal › Article
- 2014
-
Mark
Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors.
(
- Contribution to journal › Article
-
Mark
Immunizations with unmodified tumor cells and simultaneous COX-2 inhibition eradicate malignant rat brain tumors and induce a long-lasting CD8(+) T cell memory.
(
- Contribution to journal › Article
- 2013
-
Mark
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
(
- Contribution to journal › Article
-
Mark
IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models.
(
- Contribution to journal › Article
- 2012
-
Mark
The adult human brain harbors multipotent perivascular mesenchymal stem cells.
(
- Contribution to journal › Article
-
Mark
Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors.
(
- Contribution to journal › Article